Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives

Pharmacogenomics. 2017 Sep;18(14):1359-1372. doi: 10.2217/pgs-2017-0040. Epub 2017 Aug 25.

Abstract

Current treatments of opioid addiction include primarily maintenance medications such as methadone. Chronic exposure to opiate and/or long-lasting maintenance treatment induce modulations of gene expression in brain and peripheral tissues. There is increasing evidence that epigenetic modifications underlie these modulations. This review summarizes published results on opioid-induced epigenetic changes in animal models and in patients. The epigenetic modifications observed with other drugs of abuse often used by opiate abusers are also outlined. Specific methadone maintenance treatment induced epigenetic modifications at different treatment stages may be combined with the ones resulting from patients' substance use history. Therefore, research comparing groups of addicts with similar history and substances use disorders but contrasting for well-characterized treatment phenotypes should be encouraged.

Keywords: DNA methylation; drugs of abuse; epigenetics; heroin; methadone.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Line
  • DNA Methylation / drug effects*
  • Epigenesis, Genetic / drug effects*
  • Humans
  • Methadone* / adverse effects
  • Methadone* / therapeutic use
  • Opiate Substitution Treatment / methods*
  • Opiate Substitution Treatment / trends
  • Opioid-Related Disorders / drug therapy*
  • Opioid-Related Disorders / genetics
  • Pharmacogenetics*

Substances

  • Methadone